A synthetic antibody treatment developed by Regeneron reduced the risk of developing symptomatic COVID by more than 80 percent up to eight months after...
Paris—French pharmaceutical giant Sanofi said Tuesday that international Phase 3 clinical tests of its Kevzara drug for serious Covid-19 cases had proved inconclusive and...
The pharmaceutical firm Regeneron on Monday announced it was entering the late stages of its human clinical trials investigating a drug to both treat...
